Export 2761 results:
Author Title [ Type(Asc)] Year
Journal Article
T. A. G. I. S. Investigators, “The Advanced Glaucoma Intervention Study (AGIS): 8. Risk of cataract formation after trabeculectomy”, Arch Ophthalmol, vol. 119, pp. 1771-1780, 2001.
T. A. G. I. S. Investigators, “The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration”, Amer J Ophthalmol, vol. 130, pp. 429-40, 2000.
“The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration.The AGIS Investigators.”, Am J Ophthalmol, vol. 130, no. 4, pp. 429-40, 2000.
T. A. G. I. S. Investigators, “The Advanced Glaucoma Intervention Study (AGIS): 6: Effect of cataract on visual field and visual acuity”, Arch Ophthalmol, vol. 118, pp. 1639-52, 2000.
A. L. Schwartz, Van Veldhuisen, P. C., Gaasterland, D. E., Ederer, F., Sullivan, E. K., and Cyrlin, M. N., “The Advanced Glaucoma Intervention Study (AGIS): 5. Encapsulated bleb after initial trabeculectomy.”, Am J Ophthalmol, vol. 127, no. 1, pp. 8-19, 1999.
A. L. Schwartz, Van Veldhuisen, P. C., Gaasterland, D. E., Ederer, F., Sullivan, E. K., Cyrlin, M. N., and Investigators, T. A. G. I. S., “The Advanced Glaucoma Intervention Study (AGIS): 5. Encapsulated bleb after first trabeculectomy”, Am J Ophthalmol, vol. 127, pp. 8-19, 1998.
“The Advanced Glaucoma Intervention Study (AGIS): 4. Comparison of treatment outcomes within race. Seven-year results.”, Ophthalmology, vol. 105, no. 7, pp. 1146-64, 1998.
T. A. G. I. S. Investigators, “The Advanced Glaucoma Intervention Study (AGIS): 4. Comparison of treatment outcomes within race. Seven year results”, Ophthalmology, vol. 105, pp. 1146-64, 1998.
“The Advanced Glaucoma Intervention Study (AGIS): 3. Baseline characteristics of black and white patients.”, Ophthalmology, vol. 105, no. 7, pp. 1137-45, 1998.
T. A. G. I. S. Investigators, “The Advanced Glaucoma Intervention Study (AGIS): 3. Baseline characteristics of black and white patients”, Ophthalmology, vol. 105, pp. 1137-45, 1998.
J. Kim, Dally, L. G., Ederer, F., Gaasterland, D. E., VanVeldhuisen, P. C., Blackwell, B., E Sullivan, K., Prum, B., Shafranov, G., Beck, A., and Spaeth, G. L., “The Advanced Glaucoma Intervention Study (AGIS): 14. Distinguishing progression of glaucoma from visual field fluctuations.”, Ophthalmology, vol. 111, no. 11, pp. 2109-16, 2004.
J. Kim, Dally, L., Ederer, F., Gaasterland, D., Van Veldhuisen, P., Blackwell, B., Sullivan, E., Prum, B., Shafranov, G., Beck, A., Spaeth, G., and Investigators, A. G. I. S., “The Advanced Glaucoma Intervention Study (AGIS): 14. Distinguishing Progression of Glaucoma from Visual Field Fluctuations”, Ophthalmology, vol. 111, pp. 2109-2116, 2004.
F. Ederer, Gaasterland, D. A., Dally, L. G., Kim, J., VanVeldhuisen, P. C., Blackwell, B., Prum, B., Shafranov, G., Allen, R. C., and Beck, A., “The Advanced Glaucoma Intervention Study (AGIS): 13. Comparison of treatment outcomes within race: 10-year results.”, Ophthalmology, vol. 111, no. 4, pp. 651-64, 2004.
A. G. I. S. Investigators, “The Advanced Glaucoma Intervention Study (AGIS): 13. Comparison of treatment outcomes within race. Ten-year results”, Ophthalmology, vol. 111, pp. 651-664, 2004.
A. G. I. S. Investigators, “The Advanced Glaucoma Intervention Study (AGIS): 12. Baseline risk factors for sustained loss of visual field and visual acuity in patients with advanced glaucoma”, Am J Ophthalmol, vol. 134, pp. 499-512, 2002.
“The Advanced Glaucoma Intervention Study (AGIS): 12. Baseline risk factors for sustained loss of visual field and visual acuity in patients with advanced glaucoma.”, Am J Ophthalmol, vol. 134, no. 4, pp. 499-512, 2002.
“The Advanced Glaucoma Intervention Study (AGIS): 11. Risk factors for failure of trabeculectomy and argon laser trabeculoplasty.”, Am J Ophthalmol, vol. 134, no. 4, pp. 481-98, 2002.
A. G. I. S. Investigators, “The Advanced Glaucoma Intervention Study (AGIS): 11. Risk factors for failure of trabeculectomy and argon laser trabeculoplasty”, Am J Ophthalmol, vol. 134, pp. 481-498, 2002.
D. E. Gaasterland, Blackwell, B., Dally, L. G., Caprioli, J., Katz, L. J., Ederer, F., and Investigators, A. G. I. S., “The Advanced Glaucoma Intervention Study (AGIS) 10: Variability among academic glaucoma subspecialists in assessing optic disc notching”, Trans Am Ophthalmol, vol. 99, pp. 177-85, 2001.
“The Advanced Glaucoma Intervention Study: 8. Risk of cataract formation after trabeculectomy.”, Arch Ophthalmol, vol. 119, no. 12, pp. 1771-9, 2001.
“The advanced glaucoma intervention study, 6: effect of cataract on visual field and visual acuity. The AGIS Investigators.”, Arch Ophthalmol, vol. 118, no. 12, pp. 1639-52, 2000.
S. S. El-Kamary, Pasetti, M. F., Mendelman, P. M., Frey, S. E., Bernstein, D. I., Treanor, J. J., Ferreira, J., Chen, W. H., Sublett, R., Richardson, C., Bargatze, R. F., Sztein, M. B., and Tacket, C. O., “Adjuvanted intranasal Norwalk virus-like particle vaccine elicits antibodies and antibody-secreting cells that express homing receptors for mucosal and peripheral lymphoid tissues.”, J Infect Dis, vol. 202, no. 11, pp. 1649-58, 2010.
S. El-Kamary, Pasetti, M., Mendelman, P., Frey, S., Bernstein, D., Treanor, J., Ferreira, J., Chen, W., Sublett, R., Richardson, C., Bargatze, R., Sztein, M., and Tacket, C., “Adjuvanted Intranasal Norwalk Virus-Like Particle Vaccine Elicits Antibodies and Antibody-Secreting Cells That Express Homing Receptors for Mucosal and Peripheral Lymphoid Tissues”, J Infect Dis, vol. 202, pp. 1648-1658, 2010.
N. Oden, “Adjusting Moran's I for population density.”, Stat Med, vol. 14, no. 1, pp. 17-26, 1995.
O. N, “Adjusting Moran’s I for population density,”, Stat Med, vol. 14, pp. 17-26, 1995.